A high dose of the psychedelic psilocybin temporarily dissolves brain networks, Laura Sanders reported in “Psilocybin erases brain ‘fingerprints’” (SN: 8/10/24, p. 12).
In the study, a generic form of the stimulant Ritalin served as a control against psilocybin. Reader Jason Patrick asked why scientists chose that drug.
It can be hard to design studies of psychedelics because the drugs’ effects are usually obvious to both researchers and participants, Sanders says.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.